Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX23F1HCN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $19,343
Award facts
- Contract value 100% obligated
- $19,342.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Troop Support Medical awarded a $19,342.50 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4562079075 units of XOLAIR 150 MG/ML SYRINGEML to be delivered between September 5th and 26th, 2023. XOLAIR is a medication used for the treatment of asthma and chronic idiopathic urticaria. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports Department of Defense health care needs through its medical logistics programs.
Quick answers
Who was awarded contract SPE2DX23F1HCN?
SPE2DX23F1HCN was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 5, 2023.
How much is contract SPE2DX23F1HCN worth?
The government has obligated $19,343 on SPE2DX23F1HCN.
Is contract SPE2DX23F1HCN an order under another contract?
Yes. SPE2DX23F1HCN is a delivery order under SPE2DX15D9365, an indefinite delivery contract.
Was contract SPE2DX23F1HCN competed?
The extent of competition for SPE2DX23F1HCN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award